Boston Scientific Corporation vs Genuine Parts Company — how do they compare? Boston Scientific Corporation trades at $51 (market cap $74.19B), while Genuine Parts Company trades at $135.22 (market cap $18.62B). The key difference: Boston Scientific Corporation is far larger — about 4× Genuine Parts Company's market cap, and Genuine Parts Company pays a 3.15% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| BSX | GPC | |
|---|---|---|
Market Cap | $74.19B | $18.62B |
Sector | Health | Consumer Cyclical |
52-Week High | $108.14 | $149.26 |
52-Week Low | $42.63 | $92.47 |
Enterprise Value | $86.27B | $24.72B |
Dividend Yield | — | 3.15% |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →Genuine Parts sells automotive parts (about two thirds of net sales) and industrial components. The company sells vehicle parts to commercial and retail customers through roughly 9,700 stores worldwide, most of which are independently owned. Its industrial unit, primarily operating under the Motion Industries banner in the United States, supplies bearings, power transmission, industrial automation, hydraulic, and pneumatic components to maintenance, repair, and OEM clients.
Read more on GPC →